References: |
1. Decoster A, Gontier P, Dehecq E, et al.. Detection of anti-Toxoplasma immunoglobulin A antibodies by Platelia-Toxo IgA directed against P30 and by IMx Toxo IgA for diagnosis of acquired and congenital toxoplasmosis. Journal of Clinical Microbiology. 33(8):2206-2208 (1995). 2.Bonhomme A, Thirion C, Boulanger F, et al.. Toxoplasma gondii-structure variations of the antigen P30. Parasitology. 108:281-287 (1994). 3.Godard I, Estaquier J, Zenner L, et al.. Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Molecular Immunology. 31(17):1353-1363 (1994). 4.Kim K, B ?low R, Kampmeier J et al.. Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells. Infection and Immunity. American Society for Microbiology. 62(1):203-209 (1994). 5. Mineo J R, McLeod R, Mack D et al.. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are pro- duced in murine intestine after peroral infection. The Journal of Immunology. 150(9):3951-3964 (1993). |